Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 31 | 2024 | 12246 | 2.510 |
Why?
|
Genetic Predisposition to Disease | 26 | 2024 | 18076 | 1.230 |
Why?
|
Multifactorial Inheritance | 9 | 2024 | 1425 | 1.220 |
Why?
|
Mitoguazone | 1 | 2024 | 11 | 0.920 |
Why?
|
Genome-Wide Association Study | 25 | 2024 | 12808 | 0.840 |
Why?
|
Diabetes Mellitus | 9 | 2024 | 5888 | 0.800 |
Why?
|
Genetic Loci | 6 | 2024 | 2631 | 0.730 |
Why?
|
Diabetes Mellitus, Type 1 | 5 | 2024 | 3446 | 0.720 |
Why?
|
Polymorphism, Single Nucleotide | 19 | 2024 | 16044 | 0.720 |
Why?
|
Glucokinase | 1 | 2020 | 99 | 0.670 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2024 | 391 | 0.660 |
Why?
|
Prediabetic State | 1 | 2024 | 547 | 0.610 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.590 |
Why?
|
Insulin-Secreting Cells | 1 | 2024 | 899 | 0.550 |
Why?
|
Diabetes, Gestational | 3 | 2020 | 1263 | 0.520 |
Why?
|
Multigene Family | 1 | 2018 | 1081 | 0.490 |
Why?
|
Hyperglycemia | 2 | 2023 | 1389 | 0.490 |
Why?
|
Insulin Resistance | 4 | 2023 | 3989 | 0.460 |
Why?
|
Dyslipidemias | 1 | 2021 | 872 | 0.440 |
Why?
|
Genetic Variation | 8 | 2024 | 6613 | 0.440 |
Why?
|
Apolipoproteins | 1 | 2014 | 328 | 0.400 |
Why?
|
Cluster Analysis | 4 | 2024 | 2721 | 0.380 |
Why?
|
Electronic Health Records | 3 | 2024 | 4880 | 0.370 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2010 | 212 | 0.370 |
Why?
|
Genotype | 10 | 2023 | 13036 | 0.350 |
Why?
|
Metformin | 3 | 2023 | 907 | 0.340 |
Why?
|
Algorithms | 4 | 2024 | 14073 | 0.340 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 678 | 0.340 |
Why?
|
Phenotype | 11 | 2024 | 16722 | 0.340 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2010 | 341 | 0.310 |
Why?
|
Genetic Testing | 1 | 2021 | 3591 | 0.290 |
Why?
|
Open Reading Frames | 2 | 2021 | 818 | 0.270 |
Why?
|
Humans | 58 | 2024 | 766812 | 0.260 |
Why?
|
Glutathione Peroxidase | 1 | 2007 | 258 | 0.260 |
Why?
|
Bayes Theorem | 4 | 2022 | 2353 | 0.260 |
Why?
|
Breast Neoplasms | 6 | 2010 | 21162 | 0.240 |
Why?
|
Genes, BRCA2 | 1 | 2008 | 591 | 0.240 |
Why?
|
Insulin | 4 | 2022 | 6608 | 0.210 |
Why?
|
Penetrance | 2 | 2022 | 388 | 0.210 |
Why?
|
Kidney Diseases, Cystic | 1 | 2023 | 182 | 0.200 |
Why?
|
Germ-Line Mutation | 2 | 2007 | 1886 | 0.200 |
Why?
|
Models, Genetic | 2 | 2018 | 3446 | 0.190 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6575 | 0.190 |
Why?
|
Risk Factors | 12 | 2024 | 74889 | 0.180 |
Why?
|
Alleles | 5 | 2022 | 6896 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2306 | 0.170 |
Why?
|
Genetic Counseling | 1 | 2023 | 634 | 0.160 |
Why?
|
Chromatin | 2 | 2024 | 2980 | 0.160 |
Why?
|
Genetic Markers | 2 | 2018 | 2603 | 0.150 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4618 | 0.150 |
Why?
|
Founder Effect | 1 | 2018 | 185 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2021 | 1756 | 0.150 |
Why?
|
Female | 22 | 2024 | 396532 | 0.140 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3600 | 0.140 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1180 | 0.140 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 624 | 0.140 |
Why?
|
Blood Glucose | 4 | 2023 | 6422 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 614 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2007 | 3139 | 0.130 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 319 | 0.130 |
Why?
|
Risk Assessment | 4 | 2021 | 24299 | 0.130 |
Why?
|
Models, Statistical | 1 | 2010 | 5092 | 0.130 |
Why?
|
Adult | 12 | 2024 | 223305 | 0.120 |
Why?
|
Obesity | 5 | 2023 | 13090 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3108 | 0.110 |
Why?
|
Incidence | 3 | 2024 | 21527 | 0.110 |
Why?
|
Peripheral Arterial Disease | 2 | 2024 | 1304 | 0.110 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2133 | 0.110 |
Why?
|
Lipids | 2 | 2021 | 3322 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1086 | 0.110 |
Why?
|
Case-Control Studies | 6 | 2024 | 22248 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26309 | 0.110 |
Why?
|
Fetus | 1 | 2020 | 1878 | 0.100 |
Why?
|
Triglycerides | 1 | 2020 | 2441 | 0.100 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2022 | 26 | 0.100 |
Why?
|
Pedigree | 1 | 2020 | 4539 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1672 | 0.100 |
Why?
|
Pregnancy | 4 | 2023 | 30236 | 0.100 |
Why?
|
Disease Progression | 2 | 2024 | 13642 | 0.090 |
Why?
|
Middle Aged | 10 | 2024 | 223267 | 0.090 |
Why?
|
Cohort Studies | 5 | 2024 | 41706 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3915 | 0.090 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2009 | 88 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 15835 | 0.080 |
Why?
|
Sex Distribution | 1 | 2014 | 2274 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7841 | 0.080 |
Why?
|
Sulfotransferases | 1 | 2009 | 150 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2869 | 0.080 |
Why?
|
Body Mass Index | 3 | 2022 | 13050 | 0.080 |
Why?
|
Male | 12 | 2024 | 364154 | 0.080 |
Why?
|
Metabolomics | 1 | 2017 | 1674 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 792 | 0.070 |
Why?
|
Risk | 1 | 2020 | 9602 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 250 | 0.070 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2009 | 457 | 0.070 |
Why?
|
Prospective Studies | 3 | 2022 | 54872 | 0.070 |
Why?
|
Sample Size | 1 | 2010 | 844 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15425 | 0.070 |
Why?
|
Canada | 1 | 2022 | 2126 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15652 | 0.070 |
Why?
|
Sampling Studies | 1 | 2007 | 614 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2022 | 3421 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2232 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 11094 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2009 | 581 | 0.060 |
Why?
|
Carcinoma, Lobular | 1 | 2009 | 480 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1996 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3250 | 0.060 |
Why?
|
Gene Frequency | 2 | 2024 | 3624 | 0.060 |
Why?
|
Sleep | 1 | 2021 | 4814 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12985 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2024 | 128 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4249 | 0.060 |
Why?
|
Haplotypes | 1 | 2010 | 2726 | 0.060 |
Why?
|
Glipizide | 1 | 2023 | 48 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8088 | 0.050 |
Why?
|
Prognosis | 3 | 2009 | 29959 | 0.050 |
Why?
|
Exercise | 1 | 2020 | 5945 | 0.050 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 79 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10384 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2021 | 1895 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 30214 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1097 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8616 | 0.050 |
Why?
|
Aged | 7 | 2024 | 171344 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2476 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5795 | 0.050 |
Why?
|
C-Peptide | 1 | 2023 | 443 | 0.050 |
Why?
|
United States | 4 | 2024 | 72945 | 0.050 |
Why?
|
Computational Biology | 2 | 2024 | 3564 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2887 | 0.040 |
Why?
|
Antioxidants | 1 | 2007 | 1671 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2144 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 526 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 8065 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 401 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6214 | 0.040 |
Why?
|
Rare Diseases | 1 | 2024 | 630 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1382 | 0.040 |
Why?
|
Cysts | 1 | 2023 | 685 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 958 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3113 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2024 | 1350 | 0.040 |
Why?
|
Waist Circumference | 1 | 2021 | 934 | 0.030 |
Why?
|
Adipocytes | 1 | 2024 | 1196 | 0.030 |
Why?
|
Treatment Failure | 1 | 2023 | 2659 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 975 | 0.030 |
Why?
|
Genetics, Population | 1 | 2021 | 943 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4926 | 0.030 |
Why?
|
Child | 2 | 2021 | 80670 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2022 | 1044 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59548 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12826 | 0.030 |
Why?
|
Genomics | 2 | 2024 | 5922 | 0.030 |
Why?
|
Survival Analysis | 1 | 2007 | 10101 | 0.030 |
Why?
|
Young Adult | 3 | 2023 | 59939 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2023 | 2158 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3208 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12536 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2535 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2007 | 12795 | 0.020 |
Why?
|
Birth Weight | 1 | 2020 | 2123 | 0.020 |
Why?
|
Adiposity | 1 | 2022 | 1892 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 17089 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2023 | 3692 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4340 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8623 | 0.020 |
Why?
|
Societies, Medical | 1 | 2023 | 3957 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3582 | 0.020 |
Why?
|
Registries | 1 | 2007 | 8352 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2022 | 3317 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2007 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7073 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14762 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39312 | 0.020 |
Why?
|
Mice | 2 | 2019 | 81898 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7571 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8533 | 0.020 |
Why?
|
Adolescent | 2 | 2023 | 88902 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14473 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6002 | 0.010 |
Why?
|
Animals | 2 | 2019 | 168939 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36459 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42577 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22350 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81657 | 0.010 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(96)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_